Skip to content

Effectiveness of an implementation strategy of Clinical Practice Guideline for patients with anxiety disorders in Primary Care

Cluster randomized trial for evaluate the effectiveness of an implementation strategy of a clinical practice guideline for patients with anxiety disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN83365316
Enrollment
296
Registered
2010-08-04
Start date
2010-09-15
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalised anxiety disorder, panic disorder and panic attacks Mental and Behavioural Disorders Other anxiety disorders

Interventions

1. Control group: 1.1. The Clinical Practice Guideline (CPG) will be included on the official working place website 1.2. The CPG will be presented in a formative sessio

Sponsors

Carlos III Institute of Health (Instituto de Salud Carlos III) (Spain)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients older than 18 2. Diagnosed as generalised anxiety disorder, panic disorder and panic attacks by Diagnostic and Statistical Manual of Mental Disorders 4th edition (text revision) (DSM-IV-TR) 3. Signed informed consent

Exclusion criteria

Exclusion criteria: 1. Subjects that have been diagnosed of one of the following types of anxiety: 1.1. Post-traumatic stress disorders 1.2. Acute stress disorders 1.3. drug-related anxiety disorders 1.4. Anxiety disorders due to a medical or a mental illness 2. Subjects not able to read or understand Spanish language 3. Subjects that will not stay living on the Health Area in the next year after their inclusion on the study 4. Institutionalised or immobilised patients

Design outcomes

Primary

MeasureTime frame
1. Variation of 2 or more points in the Goldberg Anxiety Scale 2. Evaluative criteria 2.1. 4 or more affirmative responses in the Anxiety subscale 2.2. 2 or more affirmative responses in the Depression subscale Outcomes will be measured at baseline, 6 and 12 months.

Secondary

MeasureTime frame
1. Compliance with the Guideline recommendations on treatment 2. Information and referrals to Mental Health Services Outcomes will be measured at baseline, 6 and 12 months in data collecting notebooks

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 27, 2026